Last reviewed · How we verify
Radiesse, Xeomin, Belotero
Radiesse, Xeomin, Belotero is a Dermal fillers and neurotoxin Small molecule drug developed by Main Line Center for Laser Surgery. It is currently FDA-approved for Facial wrinkles and folds (dynamic and static), Facial volume loss and contouring, Lip augmentation and enhancement.
These are injectable dermal fillers and botulinum toxin products that restore facial volume, smooth wrinkles, and enhance facial contours through different mechanisms.
These are injectable dermal fillers and botulinum toxin products that restore facial volume, smooth wrinkles, and enhance facial contours through different mechanisms. Used for Facial wrinkles and folds (dynamic and static), Facial volume loss and contouring, Lip augmentation and enhancement.
At a glance
| Generic name | Radiesse, Xeomin, Belotero |
|---|---|
| Sponsor | Main Line Center for Laser Surgery |
| Drug class | Dermal fillers and neurotoxin |
| Modality | Small molecule |
| Therapeutic area | Dermatology/Aesthetics |
| Phase | FDA-approved |
Mechanism of action
Radiesse is a calcium hydroxylapatite filler that provides immediate volume and stimulates collagen production. Xeomin is a purified botulinum toxin type A that blocks acetylcholine release at the neuromuscular junction to relax facial muscles and reduce dynamic wrinkles. Belotero is a hyaluronic acid filler that integrates into dermal tissue to restore volume and hydration.
Approved indications
- Facial wrinkles and folds (dynamic and static)
- Facial volume loss and contouring
- Lip augmentation and enhancement
Common side effects
- Injection site pain, swelling, or bruising
- Erythema or redness at injection site
- Headache (Xeomin)
- Temporary muscle weakness or asymmetry (Xeomin)
- Nodule formation (fillers)
Key clinical trials
- Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational (PHASE4)
- Combination Therapy for Rejuvenation of the Lower Face and Neck (NA)
- Retrospective Evaluation of Combination Treatment With the Ulthera System
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Radiesse, Xeomin, Belotero CI brief — competitive landscape report
- Radiesse, Xeomin, Belotero updates RSS · CI watch RSS
- Main Line Center for Laser Surgery portfolio CI
Frequently asked questions about Radiesse, Xeomin, Belotero
What is Radiesse, Xeomin, Belotero?
How does Radiesse, Xeomin, Belotero work?
What is Radiesse, Xeomin, Belotero used for?
Who makes Radiesse, Xeomin, Belotero?
What drug class is Radiesse, Xeomin, Belotero in?
What development phase is Radiesse, Xeomin, Belotero in?
What are the side effects of Radiesse, Xeomin, Belotero?
Related
- Drug class: All Dermal fillers and neurotoxin drugs
- Manufacturer: Main Line Center for Laser Surgery — full pipeline
- Therapeutic area: All drugs in Dermatology/Aesthetics
- Indication: Drugs for Facial wrinkles and folds (dynamic and static)
- Indication: Drugs for Facial volume loss and contouring
- Indication: Drugs for Lip augmentation and enhancement
- Compare: Radiesse, Xeomin, Belotero vs similar drugs
- Pricing: Radiesse, Xeomin, Belotero cost, discount & access